Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion

Matching molecularly targeted therapies with cancer subtype-specific gene mutations is revolutionizing oncology care. However, for rare cancers this approach is problematic due to the often poor understanding of the disease's natural history and phenotypic heterogeneity, making treatment of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Genet Genomic Med
Main Authors: Sekulic, Aleksandar, Liang, Winnie S, Tembe, Waibhav, Izatt, Tyler, Kruglyak, Semyon, Kiefer, Jeffrey A, Cuyugan, Lori, Zismann, Victoria, Legendre, Christophe, Pittelkow, Mark R, Gohmann, John J, De Castro, Fernando R, Trent, Jeffrey, Carpten, John, Craig, David W, McDaniel, Timothy K
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367085/
https://ncbi.nlm.nih.gov/pubmed/25802883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mgg3.121
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados